Bio En Holdings Corp Stock Performance
| BENH Stock | USD 0 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Bio En are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Bio En Holdings Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Bio En is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Begin Period Cash Flow | 11.7 K | |
| Free Cash Flow | 3923.00 |
Bio |
Bio En Relative Risk vs. Return Landscape
If you would invest 0.22 in Bio En Holdings Corp on October 12, 2025 and sell it today you would earn a total of 0.00 from holding Bio En Holdings Corp or generate 0.0% return on investment over 90 days. Bio En Holdings Corp is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Bio, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bio En Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio En's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Bio En Holdings Corp, and traders can use it to determine the average amount a Bio En's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BENH |
Based on monthly moving average Bio En is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bio En by adding Bio En to a well-diversified portfolio.
Bio En Fundamentals Growth
Bio Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Bio En, and Bio En fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bio Pink Sheet performance.
| Return On Asset | -2.36 | |||
| Current Valuation | 62.25 M | |||
| Shares Outstanding | 77.35 M | |||
| Price To Earning | 292.86 X | |||
| EBITDA | (41.84 K) | |||
| Cash And Equivalents | 11.71 K | |||
| Total Debt | 376.25 K | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | 3.92 K | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 15.63 K | |||
About Bio En Performance
By evaluating Bio En's fundamental ratios, stakeholders can gain valuable insights into Bio En's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bio En has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bio En has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Previously, it was focused on building, operating, and maintaining a bio-mass to energy facility on the Island of Malta. The company was founded in 2014 and is headquartered in Secaucus, New Jersey. Bio-En Holdings is traded on OTC Exchange in the United States.Things to note about Bio En Holdings performance evaluation
Checking the ongoing alerts about Bio En for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Bio En Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bio En Holdings generated a negative expected return over the last 90 days | |
| Bio En Holdings has some characteristics of a very speculative penny stock | |
| Bio En Holdings Corp currently holds 376.25 K in liabilities. Bio En Holdings has a current ratio of 0.06, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Bio En until it has trouble settling it off, either with new capital or with free cash flow. So, Bio En's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bio En Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bio to invest in growth at high rates of return. When we think about Bio En's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (41.84 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| About 60.0% of the company shares are held by company insiders |
- Analyzing Bio En's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bio En's stock is overvalued or undervalued compared to its peers.
- Examining Bio En's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bio En's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bio En's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bio En's pink sheet. These opinions can provide insight into Bio En's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bio Pink Sheet analysis
When running Bio En's price analysis, check to measure Bio En's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio En is operating at the current time. Most of Bio En's value examination focuses on studying past and present price action to predict the probability of Bio En's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio En's price. Additionally, you may evaluate how the addition of Bio En to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |